122 related articles for article (PubMed ID: 2471825)
1. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
Balster RL
J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
Shannon HE
J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
Holtzman SG
Pharmacol Biochem Behav; 1993 Feb; 44(2):349-55. PubMed ID: 8446667
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
Steinfels GF; Tam SW; Cook L
Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
Picker MJ
Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
Slifer BL; Dykstra LA
Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
[TBL] [Abstract][Full Text] [Related]
7. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
8. Effects of drugs that bind to PCP and sigma receptors on punished responding.
McMillan DE; Hardwick WC; deCosta BR; Rice KC
J Pharmacol Exp Ther; 1991 Sep; 258(3):1015-8. PubMed ID: 1653832
[TBL] [Abstract][Full Text] [Related]
9. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
Itzhak Y; Hiller JM; Simon EJ
Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
[TBL] [Abstract][Full Text] [Related]
10. Effects of phencyclidine-like drugs on punished behavior in rats.
Porter JH; Wiley JL; Balster RL
J Pharmacol Exp Ther; 1989 Mar; 248(3):997-1002. PubMed ID: 2539469
[TBL] [Abstract][Full Text] [Related]
11. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
Singh L; Wong EH; Kesingland AC; Tricklebank MD
Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
[TBL] [Abstract][Full Text] [Related]
12. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
Compton DR; Bagley RB; Katzen JS; Martin BR
Life Sci; 1987 Jun; 40(22):2195-206. PubMed ID: 3035304
[TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
Colpaert FC; Janssen PA
J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
[TBL] [Abstract][Full Text] [Related]
14. (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-allylnormetazocine-like (SKF 10,047) discriminative stimuli.
Steinfels GF; Tam SW; Cook L
Life Sci; 1986 Dec; 39(26):2611-5. PubMed ID: 3796207
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
Katz JL; Spealman RD; Clark RD
J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644
[TBL] [Abstract][Full Text] [Related]
16. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine.
Beardsley PM; Balster RL
J Pharmacol Exp Ther; 1988 Jan; 244(1):34-40. PubMed ID: 3336008
[TBL] [Abstract][Full Text] [Related]
18. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.
Tricklebank MD; Singh L; Oles RJ; Wong EH; Iversen SD
Eur J Pharmacol; 1987 Sep; 141(3):497-501. PubMed ID: 2822452
[TBL] [Abstract][Full Text] [Related]
19. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
Willetts J; Rice A; Balster RL
Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
[TBL] [Abstract][Full Text] [Related]
20. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
Weissman AD; Broussolle EP; London ED
J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
